These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22704680)

  • 21. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013.
    ; Mpanya G; Tshefu A; Likwela JL
    Malar J; 2017 Feb; 16(1):94. PubMed ID: 28241832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Counterfeit and substandard antimalarial drugs in Cambodia.
    Lon CT; Tsuyuoka R; Phanouvong S; Nivanna N; Socheat D; Sokhan C; Blum N; Christophel EM; Smine A
    Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1019-24. PubMed ID: 16765399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.
    Abrha S; Tadesse E; Atey TM; Molla F; Melkam W; Masresha B; Gashaw S; Wondimu A
    BMC Pregnancy Childbirth; 2018 Nov; 18(1):464. PubMed ID: 30497441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand.
    Vijaykadga S; Cholpol S; Sitthimongkol S; Pawaphutanan A; Pinyoratanachot A; Rojanawatsirivet C; Kovithvattanapong R; Thimasarn K
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():5-10. PubMed ID: 17547041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pill characterization data streams for reducing exposure to inadequately identified anti-malarial medication in developing countries.
    Pennefather P; Ahmad AI; Crandall I; Suhanic W
    Malar J; 2010 Jul; 9():214. PubMed ID: 20649985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials.
    Gaudiano MC; Di Maggio A; Cocchieri E; Antoniella E; Bertocchi P; Alimonti S; Valvo L
    Malar J; 2007 Feb; 6():22. PubMed ID: 17316432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmaceutical death-ride of dihydroartemisinin.
    Jansen FH
    Malar J; 2010 Jul; 9():212. PubMed ID: 20649950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
    O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
    Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?
    Walker EJ; Peterson GM; Grech J; Paragalli E; Thomas J
    BMC Public Health; 2018 May; 18(1):630. PubMed ID: 29764407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
    Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
    Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria.
    Onwujekwe O; Kaur H; Dike N; Shu E; Uzochukwu B; Hanson K; Okoye V; Okonkwo P
    Malar J; 2009 Feb; 8():22. PubMed ID: 19208221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
    ; Tougher S; Hanson K; Goodman C
    Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary enquiry into the availability, price and quality of malaria rapid diagnostic tests in the private health sector of six malaria-endemic countries.
    Albertini A; Djalle D; Faye B; Gamboa D; Luchavez J; Mationg ML; Mwangoka G; Oyibo W; Bennett J; Incardona S; Lee E
    Trop Med Int Health; 2012 Feb; 17(2):147-52. PubMed ID: 22032415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria.
    Nwokolo E; Ujuju C; Anyanti J; Isiguzo C; Udoye I; BongosIkwue E; Ezire O; Raji M; Oyibo WA
    Int J Health Policy Manag; 2018 Jun; 7(6):542-548. PubMed ID: 29935131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to malaria diagnosis and treatment guidelines among healthcare workers in Ogun State, Nigeria.
    Bamiselu OF; Ajayi I; Fawole O; Dairo D; Ajumobi O; Oladimeji A; Steven Y
    BMC Public Health; 2016 Aug; 16(1):828. PubMed ID: 27538947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
    ; Hanson K; Goodman C
    Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimalarial drug quality in the most severely malarious parts of Africa - a six country study.
    Bate R; Coticelli P; Tren R; Attaran A
    PLoS One; 2008 May; 3(5):e2132. PubMed ID: 18461128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.